MedTrace Logo

Creatine and Ubiquinol for Sperm Quality

NCT06202469 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-12-04

No results posted yet for this study

Summary

This randomized controlled double-blind parallel-group interventional trial explores the impact of 8-week creatine supplementation, with or without ubiquinol, on sperm quality biomarkers in normospermic and oligospermic men. It aims to determine potential enhancements in sperm health to provide insights into male fertility and reproductive health improvement strategies.

Conditions

  • Oligospermia
  • Sperm Count, Low

Interventions

DIETARY_SUPPLEMENT

Supplement 1

Creatine monohydrate (5 g/day)

DIETARY_SUPPLEMENT

Supplement 2

Creatine monohydrate (5 g/day) plus ubiquinol (200 mg/day)

DIETARY_SUPPLEMENT

Placebo

Placebo (inulin)

Sponsors & Collaborators

  • University of Novi Sad, Faculty of Sport and Physical Education

    lead OTHER

Principal Investigators

  • Sergej Ostojic, MD, PhD · University of Novi Sad

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-15
Primary Completion
2024-05-31
Completion
2024-06-30

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06202469 on ClinicalTrials.gov